Clinical Trials Browser

Phase 1 × Active not recruiting × Solid Malignancies × Clear all

NCT05006794 2026-01-07

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Phase 1 Active not recruiting

Solid Malignancies

NCT02537418 2025-08-19

Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens

Phase 1 Active not recruiting

Solid Malignancies